Pharmaceutical Biotechnology. Questo articolo non è disponibile.
Lingua: inglese
Editore: Springer, 2024
- Rilegato
- Nuovo
Da: PBShop.store UK, Fairford, GLOS, Regno UnitoPBShop.store UK
Venditore AbeBooks dal 11 giugno 1999
Condizione: Nuovo
EUR 81,07
Descrizione dell’articolo da parte del venditore
New Book. Shipped from UK. Established seller since 2000.
Codice articolo GB-9783031300226
- Titolo
- Pharmaceutical Biotechnology
- Editore
- Springer
- Anno di pubblicazione
- 2024
- Condizione
- New
- Rilegatura
- HRD
- Lingua
- inglese
- ISBN 10
- 303130022X
- ISBN 13
- 9783031300226
- Peso dell'articolo
- 2020 grammi
This introductory text explains both the basic science, production, quality, dosage forms, administration, economic and regulatory aspects and the clinical applications of biotechnology-derived pharmaceuticals. It serves as a complete one-stop source for undergraduate/graduate pharmacists and pharmaceutical science students. An additional important audience are pharmaceutical scientists in industry and academia, particularly those who have not received formal training in pharmaceutical biotechnology and are inexperienced in this field. The rapid growth and advances in the field made it necessary to revise this textbook in order to continue providing up-to-date information and introduce readers to cutting edge knowledge and technology of this field. This Sixth Edition completely updates the previous edition and includes additional coverage on new approaches such as oligonucleotides, siRNA, mRNA, gene therapy, cell therapies, monoclonal antibodies and vaccines. With more than 3-million-chapter downloads, the fifth edition of the textbook has achieved widespread distribution as a key educational resource for the field of pharmaceutical biotechnology.
"Riassunto" può appartenere a un’altra edizione di questo titolo.
Informazioni sull’autore
Daan J.A. Crommelin is Professor Emeritus, Department of Pharmaceutical Sciences, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherland. He is an elected fellow of the International Pharmaceutical Federation (FIP) and the American Association of Pharmaceutical Scientists (AAPS).
Robert D. Sindelar is a Professor and Dean Emeritus, Faculty of Pharmaceutical Sciences, The University of British Columbia (UBC). He is an elected fellow of the Canadian Academy of Health Sciences, and an elected fellow of the International Pharmaceutical Federation (FIP). He previously served as Vice President of Innovation, Research & Academic Affairs at Providence Health Care (PHC), President of the PHC Research Institute and Associate Dean Research in the UBC Faculty of Medicine
Bernd Meibohm is Distinguished Professor, Associate Dean for Research and Graduate Programs, and Chair of the Department of Pharmaceutical Sciences at the University of Tennessee Health Science Center College of Pharmacy, Memphis, Tennessee, USA. He is an elected fellow of the American College of Clinical Pharmacology (ACCP) and the American Association of Pharmaceutical Scientists (AAPS).
"Descrizione articolo" può appartenere a un’altra edizione di questo titolo.